BioWorld

March 20, 2002

View Archived Issues

Unified FDA Panel Votes 15-0 Against ViroPharma’s Picovir

GAITHERSBURG, Md. A government panel on Tuesday flatly rejected ViroPharma Inc.’s application for Picovir, an investigational drug that reduces the duration of a cold by one day. (BioWorld Today) Read More

Devious Pulmonary Pro-Asthma Process Sucks In Inflammatory Cells, Can’t Spit Them Back Out

Read More

Neurocrine Biosciences Launches Broad Phase III Insomnia Program

Read More

Other News To Note

Read More

Corixa Enters Breast Cancer Diagnostics Deal With J&J

Read More